Despite the positive role of an active SHP2 in managing obesity by activating leptin receptors (LepRb) in the hypothalamus, threatening consequences of active mutant Shp2 exist, such as the development of tumors [73]. The gene discussed is PTPN11; the disease is obesity due to melanocortin 4 receptor deficiency.